Relationship between anthropometric characteristics and its repercussion in Type-2 Diabetes Mellitus
Keywords:
Diabetic angiopathies/complications, Type-2 Diabetes Mellitus/complications/diagnosis, Obesity/complications/epidemiology.Abstract
The interrelation between obesity and type-2 diabetes mellitus is very important from the clinical and epidemiological view points. This study was aimed at assessing the association between vascular risk and anthropometric variables in patients with type-2 diabetes mellitus, where the body-mass index and the abdominal size were evaluated in relation to the presence of chronic vascular complications in these patients. One hundred twenty (120) patients from 40 to 79 years old, attending to the diabetes mellitus office at “Hermanos Ameijeiras” University Hospital from October 2009 to September 2010 were included in the study considering the medical history, complementary and general clinical examinations. Body-mass index, abdominal size (AS), insulinemia and C-peptide were also determined; (IMC ≥ de 30 kg/m2 sc) was taken as obesity risk and the augmented abdominal size (in men >102 cm and in women > 88) and these values were related to vascular complications together with C-peptide and insulinemia on empty stomach. Results were statistically analyzed having a significance of p<0.05. Obesity (48,3%) and abdominal size (67,5%) prevailed. Both, the obese ones and those presenting high C-peptide values and insulinemia showed no differences among them. Vascular chronic complications prevailed in type-2 diabetic patients and in those with augmentation of the abdominal fat.Downloads
References
1. Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance Síndrome: mediators, antecedents and measurement. Diabetes Care 2006; 29(7):1700-6. Available from: http://care.diabetesjournals.org/content/29/7/1700.full
2. Khoo CM, Liew CF, Chew SK, Tai ES. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome. Obesity 2007; 15(1): 262-9. Available from: http://www.nature.com/oby/journal/v15/n1/full/oby2007559a.html
3. Ridderstale M, Gudbjornsdottir S, Eliasson B. Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med. 2006; 259(3):314-22. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2006.01617.x/pdf
4. Abdul-Ghani MA, Tripathy D, Defronzo RA. Contributions of Beta cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006; 29(5):1130-9. Available from: http://care.diabetesjournals.org/content/29/5/1130.long
5. Wahrenberg H, Leijonhufvud G, Persson L. Use of waist circumference to predict insulin resistance: retrospective study. Brit Med J. 2007; 330:1363-4. Available from: http://www.bmj.com/content/330/7504/1363
6. Rosenzweig J, Ferrannini E, Grundy S, Haffner S, Heine R, Horton E, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93(10):3671-89. Available from: http://jcem.endojournals.org/content/93/10/3671.full.pdf+html
7. Cuba. MINSAP. Programa Nacional de Prevención, Diagnóstico, Evaluación y Control de la Hipertensión Arterial: Guía para la atención médica. La Habana: MINSAP; 2006.
8. Garrow JS, Webster J. Quetelet's Index (W/H2) as a measure of fatness. Int J Obes. 1985; 9:147-53.
9. Socarrás Suárez MM, Bolet Astoviza M, Licea Puig M. Obesidad: tratamiento no farmacológico y prevención. Rev Cubana Endocrinol. 2002; 13:35-42.
10. Sierra ID, Mendivil CO, Hernández B. Manual de manejo integral del riesgo cardiovascular. 2. ed. Bogotá: Horizontes; 2003. p 43-5.
11. Guías ALAD de diagnóstico, control y tratamiento de la Diabetes Mellitus tipo 2 [Internet]. s/l: s/n; 2006 [citado 12 Feb 2010]. Disponible en: http://wwwsld.cu/sitios/diabetes/
12. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diabetes Vasc Dis Res. 2007; 4:13-9.
13. Sereday M, Damiano M, Lapertosa S. Complicaciones crónicas en personas con diabetes mellitus tipo 2 de reciente diagnóstico. Endocrinol Nutr. 2008; 55:64-8.
14. Valdés R, Bencosme E, Rodríguez N. Frecuencia de la hipertensión arterial y su relación con algunas variables clínicas en pacientes con diabetes mellitus tipo 2. Rev Cubana Endocrinol, Dic 2009; 20(3): 77-88.
15. Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol. 2007; 99(4A):6-14.
16. Aschner P, Ruiz A, Balkau B, Massien CH, Haffner S. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America. J Cardiometab Synd. 2008; 13:1559-72.
17. Vásquez A, Pereira P, Gomide R, Batista M, Campos M, Sant'Ana L, et al. Influence of body weight excess and central adiposity in glycemic and lipid profile in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2007; 51:1516-21.
18. Nasiff Hadad A, Pérez Pérez L, Campos Nodarse A, Dueñas Herrera A, Espinosa Brito A, Herrera González A, et al. Primer consenso nacional de dislipoproteinemias: Guía para la prevención, detección, diagnóstico y tratamiento. Rev Cubana Endocrinol (Suplemento). 2006; 17:1-31.
19. Reyes A, Navarro J, Islas M, Castro L, Gómez L, Narváez C, et al. Prevalencia del síndrome metabólico en relación con las concentraciones de ácido úrico. Med Int Mex. 2009; 25:278-84.
20. Chuang S, Chou P, Hsu P, Cheng H, Tsai S, Lin I, et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens. 2006; 19:788-95.

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/